|
|
|
|
1 Neuroendocrine Response and Shock |
|
|
3 | (6) |
|
|
|
|
|
2 The Role of Lymphocytes in the Pathogenesis of Atherosclerosis: Focus on CD4+ T Cell Subsets |
|
|
9 | (6) |
|
|
|
|
|
3 Immunological Mechanisms of Inflammation |
|
|
15 | (14) |
|
|
|
|
|
Alberto Jose da Silva Duarte |
|
|
|
|
|
4 Role of Lipoproteins in Carotid Arterial Disease |
|
|
29 | (8) |
|
|
|
|
|
5 Carotid Endarterectomy: Inflammatory Aspects |
|
|
37 | (4) |
|
|
|
|
|
6 Endovascular Treatment of Carotid Disease: Inflammatory Aspects |
|
|
41 | (6) |
|
|
|
|
|
Part III Abdominal Aortic Aneurysm |
|
|
|
7 Role of Matrix Metalloproteinases and Aortic Wall Degradation in Abdominal Aortic Aneurysms |
|
|
47 | (4) |
|
|
|
|
|
8 Role of Haptoglobin in Abdominal Aortic Aneurysm |
|
|
51 | (6) |
|
|
|
9 Inflammatory Aortic Aneurysm |
|
|
57 | (6) |
|
Guilherme Vieira Meirelles |
|
|
10 Endovascular Treatment of Abdominal Aortic Aneurysms: Current Approaches and New Devices |
|
|
63 | (10) |
|
Armando de Carvalho Lobato |
|
|
Robert Guimaraes do Nascimento |
|
|
Ariele Milano de Oliveira |
|
|
11 Endovascular Treatment of Ruptured Abdominal Aortic Aneurysms |
|
|
73 | (6) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Part IV Critical Lower Limb Ischemia |
|
|
|
12 Thromboangiitis Obliterans |
|
|
79 | (12) |
|
Otacilio de Camargo Junior |
|
|
|
|
13 Inflammatory Markers and Mortality in Critical Lower Limb Ischemia |
|
|
91 | (6) |
|
|
|
14 Arterial Wall Remodeling and Restenosis Following Vascular Reconstruction |
|
|
97 | (10) |
|
|
|
|
|
15 Shear Stress and Endothelial Cell Retention in Critical Lower Limb Ischemia |
|
|
107 | (10) |
|
|
|
|
|
16 Arterial Transplantation for Limb Salvage |
|
|
117 | (8) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17 Disseminated Intravascular Coagulation in Vascular Trauma |
|
|
125 | (6) |
|
|
|
|
|
|
|
|
|
18 Temporary Intravascular Shunt in Complex Vascular Injury |
|
|
131 | (10) |
|
|
|
|
|
|
|
|
19 Metalloproteinases in Acute Venous Occlusion |
|
|
141 | (12) |
|
|
|
20 Idiopathic Venous Thromboembolism |
|
|
153 | (22) |
|
|
|
21 Inflammation, Thrombogenesis, Fibrinolysis, and Vein Wall Remodeling After Deep Venous Thrombosis |
|
|
175 | (10) |
|
|
|
|
|
22 Varicose Veins: Venous Wall Changes, Inflammation, and Matrix Metalloproteinases |
|
|
185 | (8) |
|
|
|
Part VII Visceral Vasculopathy |
|
|
|
23 Management of Aneurysms in Takayasu's Arteritis |
|
|
193 | (12) |
|
|
|
|
|
|
|
|
|
205 | (10) |
|
|
|
|
|
Part VIII Peripheral Aneurysms |
|
|
|
25 Inflammatory Peripheral Arterial Aneurysms |
|
|
215 | (6) |
|
|
|
|
|
|
|
|
|
|
|
|
|
26 Endovascular Femoropopliteal Interventions: Evolving Devices |
|
|
221 | (10) |
|
|
|
|
|
Part IX Cardiopulmonary Bypass |
|
|
|
27 Modulation of Inflammatory Response in Cardiopulmonary Bypass |
|
|
231 | (14) |
|
|
|
28 The Systemic Inflammatory Response Syndrome Following Cardiopulmonary Bypass in Children |
|
|
245 | (10) |
|
|
|
|
|
29 Vacuum-Assisted Venous Drainage in Cardiac Surgery |
|
|
255 | (4) |
|
|
|
|
|
|
|
30 Miniaturize CPB Versus Off-Pump Surgery |
|
|
259 | (6) |
|
|
|
31 Thyroid Hormones and Cardiovascular Surgery |
|
|
265 | (10) |
|
|
|
|
|
32 Inflammatory Response in Cardiovascular Surgery |
|
|
275 | (6) |
|
|
|
33 Lung Protection in Cardiovascular Surgery |
|
|
281 | (8) |
|
|
|
|
|
Part X Coronary Artery Disease |
|
|
|
34 Fifteen Years of `No-Touch' Saphenous Vein Harvesting in Patients Undergoing Coronary Artery Bypass Surgery: What Have We Learned? |
|
|
289 | (10) |
|
|
|
|
|
35 Platelets and Coronary Artery Disease |
|
|
299 | (8) |
|
|
|
|
|
|
|
Part XI Heart Valve Diseases |
|
|
|
36 Role of Bone Morphogenetic Proteins in Valvulogenesis |
|
|
307 | (10) |
|
|
|
|
|
37 Dysfunctional Mechanisms of Anti-inflammation in Aortic Stenosis |
|
|
317 | (4) |
|
|
|
|
|
38 Heart Valve Surgery and the Antiphospholipid Syndrome |
|
|
321 | (12) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Part XII Congenital Heart Diseases |
|
|
|
39 Neurohormonal Factors in Pediatric Heart Surgery |
|
|
333 | (8) |
|
|
|
40 Antifibrinolytic Therapy in Pediatric Congenital Heart Surgery |
|
|
341 | (8) |
|
|
|
41 Thromboembolism in Cyanotic Heart Disease: Mechanisms and Therapies |
|
|
349 | (6) |
|
|
|
42 Endovascular Management of Coarctation of the Aorta |
|
|
355 | (14) |
|
|
|
Part XIII Thoracoabdominal Aortic Aneurysm |
|
|
|
43 Inflammatory Response in Open and Endovascular Treatment |
|
|
369 | (6) |
|
|
|
|
|
44 Surgical Treatment of Aortic Aneurysm in Patients with Aortitis |
|
|
375 | (10) |
|
|
|
|
|
Part XIV Heart and Lung Transplantation |
|
|
|
45 Cytokine Profile in Heart Transplantation |
|
|
385 | (8) |
|
|
|
|
|
|
|
|
|
46 Platelet Activation After Lung Transplantation |
|
|
393 | (6) |
|
|
|
|
|
47 Role of BNP in Pediatric Heart Transplantation |
|
|
399 | (4) |
|
|
|
|
|
48 Nutritional factors, Oxidative Stress and Lung Transplantation |
|
|
403 | (10) |
|
|
|
|
|
|
|
|
|
Part XV Ventricular Assist Device |
|
|
|
49 Mechanical Unloading and Heart Remodeling Features |
|
|
413 | (8) |
|
|
|
|
|
|
|
|
|
Part XVI Stem Cells in Cardiovascular Surgery |
|
|
|
50 Cytokine Profiles in Cardiac Diseases and Marrow Stromal Cells Therapy |
|
|
421 | (6) |
|
|
|
|
|
|
|
51 Hypoxic Preconditioning of Cardiac Progenitor Cells for Ischemic Heart |
|
|
427 | (10) |
|
|
|
|
| Index |
|
437 | |
